Results for tag: "Sargramostim"

Sargramostim is a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) used to treat immune disorders. It is used to stimulate the production of white blood cells, which are important for fighting infection. It is used to treat neutropenia, a condition in which the body does not produce enough white blood cells, and to reduce the risk of infection in patients with HIV/AIDS. It is also used to treat certain types of cancer, such as leukemia and lymphoma, and to reduce the side effects of chemotherapy. Sargramostim is administered as an injection or intravenous infusion. It is available in both brand-name and generic forms. Common side effects include fever, chills, nausea, vomiting, and headache. The Sargramostim market is a growing segment of the immune disorders drugs market. It is used to treat a variety of conditions, including neutropenia, HIV/AIDS, and certain types of cancer. It is also used to reduce the side effects of chemotherapy. Some companies in the Sargramostim market include Amgen, Merck, Pfizer, and Novartis. Show Less Read more